Cited by 61MicroRNA in disease regulationTreatment of Major DepressionTryptophan and brain disorders

The DOI matches its Crossref record; 287 of the 296 references it cites were found in a registry or an index.

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective

Open access
Ortega, Miguel A., Alvarez-Mon, Miguel Angel, García-Montero, Cielo, Fraile-Martinez, Oscar, Lahera, Guillermo, Monserrat, Jorge, Muñoz-Merida, Luis, Mora, Fernando, Rodríguez-Jiménez, Roberto, Fernandez-Rojo, Sonia, Quintero, Javier, Álvarez-Mon, Melchor·2021·Biomedicines

Abstract

Major Depressive Disorder (MDD) represents a major global health concern, a body-mind malady of rising prevalence worldwide nowadays. The complex network of mechanisms involved in MDD pathophysiology is subjected to epigenetic changes modulated by microRNAs (miRNAs). Serum free or vesicles loaded miRNAs have starred numerous publications, denoting a key role in cell-cell communication, systematically and in brain structure and neuronal morphogenesis, activity and plasticity. Upregulated or downregulated expression of these signaling molecules may imply the impairment of genes implicated in pathways of MDD etiopathogenesis (neuroinflammation, brain-derived neurotrophic factor (BDNF), neurotransmitters, hypothalamic-pituitary-adrenal (HPA) axis, oxidative stress, circadian rhythms...). In addition, these miRNAs could serve as potential biomarkers with diagnostic, prognostic and predictive value, allowing to classify severity of the disease or to make decisions in clinical management. They have been considered as promising therapy targets as well and may interfere with available antidepressant treatments. As epigenetic malleable regulators, we also conclude emphasizing lifestyle interventions with physical activity, mindfulness and diet, opening the door to new clinical management considerations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines9111659

Cites

287 of 287 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mechanisms involved in the etiopathogenesis of MDD in which miRNAs may be key mediators BBB: blood brain barrier. 5-HT: serotonin. DA: dopamine. NE: norepinephrine. GABA: gamma-aminobutyric acid. MGB axis: microbiota-gut-brain axis. HPA axis: hypothalamic-pituitary-adrenal axis. Kyn: kynurenine. LPS: lipopolysaccharide.
Figure 1 Mechanisms involved in the etiopathogenesis of MDD in which miRNAs may be key mediators BBB: blood brain barrier. 5-HT: serotonin. DA: dopamine. NE: norepinephrine. GABA: gamma-aminobutyric acid. MGB axis: microbiota-gut-brain axis. HPA axis: hypothalamic-pituitary-adrenal axis. Kyn: kynurenine. LPS: lipopolysaccharide.CC BY · PubMed Central
Figure 2 A general picture of the molecular background of miRNAs in MDD. As showed, there are multiple pathways affected by the dysregulation of a set of miRNAs in this mental disorder. Some of their molecular targets are involved in critical pathophysiological mechanisms of MDD, and either the upregulation (represented in green) or downregulation (In red) may be partly responsible for the changes in the neurons and glial cells of depressed individuals. Some of these alterations have been reported in critical areas of the brain such as the amygdala or the hippocampus, clearly implicated in the etiopathogenesis of MDD. Finally, there are some miRNAs that may be regulated by the exposure to the pathological environment including after acute or prolonged stress or due to the endotoxemia and neuroinflammation.
Figure 2 A general picture of the molecular background of miRNAs in MDD. As showed, there are multiple pathways affected by the dysregulation of a set of miRNAs in this mental disorder. Some of their molecular targets are involved in critical pathophysiological mechanisms of MDD, and either the upregulation (represented in green) or downregulation (In red) may be partly responsible for the changes in the neurons and glial cells of depressed individuals. Some of these alterations have been reported in critical areas of the brain such as the amygdala or the hippocampus, clearly implicated in the etiopathogenesis of MDD. Finally, there are some miRNAs that may be regulated by the exposure to the pathological environment including after acute or prolonged stress or due to the endotoxemia and neuroinflammation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 296 references

Cited by

Sorted by citations

See all 61

Metadata

Authors
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Lahera, G., Monserrat, J., Muñoz-Merida, L., Mora, F., Rodríguez-Jiménez, R., Fernandez-Rojo, S., Quintero, J., & Álvarez-Mon, M.
Affiliations
  • Universidad de Alcalá (ES)
  • Department of Medicine and Medical Specialities, University of Alcala, 28801 Alcalá de Henares, Spain
  • Universidad Complutense de Madrid (ES)
  • Department of Legal Medicine and Psychiatry, Complutense University, 28040 Madrid, Spain
  • Cancer Registry and Pathology Department, Hospital Universitario Principe de Asturias, 28806 Alcalá de Henares, Spain
Venue
Biomedicines
Publisher
MDPI AG
Published
2021-11-10
Volume
9
Issue
11
Pages
1659
ISSN
2227-9059 (ISSN-L)
OpenAlex
W3211397738
Cited by
57
References
296
Citations by year
2026: 13 · 2025: 14 · 2024: 11 · 2023: 10 · 2022: 9
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Instituto de Salud Carlos III (PI18/01726)
  • Comunidad de Madrid (B2017/BMD3804)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
major depressive disorder, microRNA, biomarkers, epigenetics, serum microRNA, extracellular vesicles, neuroinflammation, brain-derived neurotrophic factor, hypothalamic-pituitary-adrenal axis, oxidative stress, circadian rhythm, antidepressant targets, lifestyle intervention, physical activity, mindfulness, diet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review